Jo Varshney / VeriSIM Life
VeriSIM Life, an AI-enabled R&D decision de-risker for drug development, announced that its founder and CEO, Jo Varshney, has been awarded the Gold Stevie Award in the healthcare category during the 20th annual Stevie Awards for Women in Business.
The Stevie Awards acknowledge the world's top women entrepreneurs, executives, and employees. This year saw over 1,600 nominations, spanning 100 categories.
Varshney, was one of the seven finalists for “Most Innovative Woman of the Year – Healthcare” award. It recognized Varshney’s leadership in the novel use of artificial intelligence and machine learning to enhance the value of drug candidate intellectual property early in the development lifecycle.
Originally from India, Varshney relocated to the United States in 2010 to pursue studies in comparative oncology, genomics, and bioinformatics. Her journey began by addressing the challenges of translating drug candidates from the laboratory to clinical trials. After winning a hackathon with her concept, she founded VeriSIM Life, a company centered around AI-enabled drug development.
"I am honored to be chosen as the 2023 recipient of the Gold Stevie Award alongside so many influential women in the healthcare field from all over the world," said Varshney. "This award is a testament to each woman who has dedicated their lives to innovation in the healthcare industry."